BT18

CAS No. 924811-53-0

BT18 ( —— )

Catalog No. M24975 CAS No. 924811-53-0

BT18 is a mimic with function similar to glial cell line-derived neurotrophic factor (GDNF).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 In Stock
5MG 72 In Stock
10MG 132 In Stock
25MG 242 In Stock
50MG 410 In Stock
100MG 621 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BT18
  • Note
    Research use only, not for human use.
  • Brief Description
    BT18 is a mimic with function similar to glial cell line-derived neurotrophic factor (GDNF).
  • Description
    BT18 is a mimic with function similar to glial cell line-derived neurotrophic factor (GDNF). BT18 has an effect on RET receptor tyrosine kinase RetA and GDNF family receptor GFRα1 function.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    924811-53-0
  • Formula Weight
    637.6
  • Molecular Formula
    C30H31F4N3O6S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 98 mg/mL (153.69 mM; Need ultrasonic)
  • SMILES
    COc(ccc(S(N(CC1)Cc(cc2OC)c1cc2OC)(=O)=O)c1)c1N(CC1)CCN1C(c(cc1)c(C(F)(F)F)cc1F)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Bifendatatum

    Bifendatatum is commonly used to treat the transaminase elevation that caused by viral hepatitis and drug induced liver injury.

  • Rheochrysidin

    Physcion is an anthraquinone from roots of Rheum officinale Baill.

  • Iobenguane sulfate

    Iobenguane sulfate is a high-affinity substrate for cholera toxin that interferes with cellular mono(ADP-ribosylation). Radioiodinated Iobenguane sulfate is clinically used as a tumor-targeted radiopharmaceutical in the diagnosis and treatment of adrenergic tumors.